Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1994-03-10
1996-06-25
Adams, Donald E.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
4352401, 4352523, 4353201, C12N 516, C12N 522, C12N 1500
Patent
active
055299210
ABSTRACT:
The present invention relates to a rational, elegant means of producing, loading and using Class I molecules to specifically activate CD8 cells in vitro, and their therapeutic applications in the treatment of a variety of conditions, including cancer, tumors or neoplasias, as well as viral, retroviral, autoimmune, and autoimmune-type diseases. The present invention also relates to vectors, cell lines, recombinant DNA molecules encoding human .beta.2 microglobulin or Class I MHC molecules in soluble and insoluble form, and methods of producing same.
REFERENCES:
ATCC Catalogue pp. 47, 48, 72 & 73 (1992).
Osband et al Immunology Today 11(6):193-195 (1990).
Basse et al. Cancer Immunol. Immunother. 34:221-227 (1992).
Levy et al. Int. Imm. 2(10):995-1002 (1990).
Angelichio et al NAR 19(18):5037-5043 (1991).
Jackson Michael
Langlade-Demoyen Pierre
Peterson Per A.
Adams Donald E.
Scripps Research Institute
LandOfFree
In vitro activation of cytotoxic t-cells using insect cells expr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vitro activation of cytotoxic t-cells using insect cells expr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro activation of cytotoxic t-cells using insect cells expr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2188338